The utility of bipolar electrocautery in hereditary hemorrhagic telangiectasia.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 16730547.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The surgical treatment of epistaxis associated with hereditary hemorrhagic telangiectasia (HHT) is varied. Laser therapy is often inadequate for larger complex lesions. This study sought to determine if bipolar cautery can be effectively and safely used in treating HHT-associated epistaxis. Records from all patients with HHT treated surgically over 8 years were reviewed retrospectively. Outcomes or complications were noted in the clinic on follow-up evaluation. Twenty-seven patients with HHT who underwent surgical treatment of epistaxis were evaluated; 18 were treated with bipolar cautery. Forty-two separate bipolar treatments were performed. No new septal perforations or synechiae were noted. Twenty-two of 42 treatments were coupled with ancillary laser treatments. The bipolar was also used as the sole technique in 20 procedures. Bipolar electrocautery is a safe and effective tool for the intraoperative control of HHT-related epistaxis. Bipolar electrocautery may be used as an adjunct to laser techniques or as a stand-alone technique. C-4.
Medical subject headings
- Electrocoagulation
- Epistaxis
- Telangiectasia, Hereditary Hemorrhagic